Literature DB >> 8719788

The pharmacological properties of K+ currents from rabbit isolated aortic smooth muscle cells.

F C Halliday1, P I Aaronson, A M Evans, A M Gurney.   

Abstract

1. Using the whole-cell patch-clamp technique, the effects of several K+ channel blocking drugs on K+ current recorded from rabbit isolated aortic smooth muscle cells were investigated. 2. Upon depolarization from -80 mV, outward K+ current composed of several distinct components were observed: a transient, 4-aminopyridine (4-AP)-sensitive component (I1) and a sustained component (Isus), comprising a 4-AP-sensitive delayed rectifier current (IK(V)), and a noisy current which was sensitive to tetraethylammonium (TEA), and probably due to Ca(2+)-activated K+ current (IK(Ca)). 3. Several drugs in clinical or experimental use have as part of their action an inhibitory effect on specific K+ channels. Because of their differential K+ channel blocking effects, these drugs were used in an attempt to characterize further the K+ channels in rabbit aortic smooth muscle cells. Imipramine, phencyclidine, sotalol and amitriptyline failed to block selectively any of the components of K+ current, and were thus of little value in isolating individual channel contributions. Clofilium showed selective block of IK(V) in the presence of TEA, but only at low stimulation frequencies (0.07 Hz). At higher frequencies (1 Hz) of depolarization, both I1 and IK(V) were suppressed to a similar extent. Thus, the blocking action of clofilium was use-dependent. 4. The voltage-dependent inactivation of I1 and the delayed rectifier were very similar although a brief (100 ms) pre-pulse to -30 mV could preferentially inactivate I1. Together with the non-selective blocking effects of the K+ channel blockers, similarities in the activation and inactivation of these two components suggest that they may not exist as separate ionic channels, but as distinct kinetic states within the same K+ channel population. 5. The effects of all of these drugs on tension were examined in strips of rabbit aorta. The non-specific K+ channel blockers caused only minor increases in basal tension. TEA and 4-AP by themselves caused significant increases in tension and were even more effective when applied together. There appeared to be no correlation between the effects of the drugs tested on tension and their actions on currents recorded from isolated myocytes. Thus tension studies are an inappropriate means of investigating the mechanism of action of these drugs, and studies on ionic currents in isolated myocytes cannot easily predict drug actions on intact tissues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8719788      PMCID: PMC1909192          DOI: 10.1111/j.1476-5381.1995.tb15116.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  Two Ca-dependent K-channels classified by the application of tetraethylammonium distribute to smooth muscle membranes of the rabbit portal vein.

Authors:  R Inoue; K Kitamura; H Kuriyama
Journal:  Pflugers Arch       Date:  1985-10       Impact factor: 3.657

2.  Patch and whole-cell voltage clamp of single mammalian visceral and vascular smooth muscle cells.

Authors:  T B Bolton; R J Lang; T Takewaki; C D Benham
Journal:  Experientia       Date:  1985-07-15

3.  Rabbit aorta: electrical properties and agonist-induced depolarization.

Authors:  G Haeusler; J E De Peyer
Journal:  Eur J Pharmacol       Date:  1989-07-18       Impact factor: 4.432

4.  Actions of phencyclidine on the action potential and membrane currents of single guinea-pig myocytes.

Authors:  R W Hadley; J R Hume
Journal:  J Pharmacol Exp Ther       Date:  1986-04       Impact factor: 4.030

5.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

6.  The membrane properties of the smooth muscle cells of the rabbit main pulmonary artery.

Authors:  R Casteels; K Kitamura; H Kuriyama; H Suzuki
Journal:  J Physiol       Date:  1977-09       Impact factor: 5.182

7.  Macroscopic K+ currents in single smooth muscle cells of the rabbit portal vein.

Authors:  J R Hume; N Leblanc
Journal:  J Physiol       Date:  1989-06       Impact factor: 5.182

8.  Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers.

Authors:  E Carmeliet
Journal:  J Pharmacol Exp Ther       Date:  1985-03       Impact factor: 4.030

9.  Block of heart potassium channels by clofilium and its tertiary analogs: relationship between drug structure and type of channel blocked.

Authors:  J P Arena; R S Kass
Journal:  Mol Pharmacol       Date:  1988-07       Impact factor: 4.436

10.  Anti-vasoconstrictor effects of the K+ channel opener cromakalim on the rabbit aorta--comparison with the calcium antagonist isradipine.

Authors:  N S Cook; S W Weir; M C Danzeisen
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

View more
  4 in total

Review 1.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

2.  A-type potassium current in retinal arteriolar smooth muscle cells.

Authors:  Mary K McGahon; Jennine M Dawicki; C Norman Scholfield; J Graham McGeown; Tim M Curtis
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-09       Impact factor: 4.799

3.  Mechanisms of hydralazine induced vasodilation in rabbit aorta and pulmonary artery.

Authors:  D C Ellershaw; A M Gurney
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

4.  Characterisation of K+ channels in human fetoplacental vascular smooth muscle cells.

Authors:  Melissa F Brereton; Mark Wareing; Rebecca L Jones; Susan L Greenwood
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.